Cathelicidins: Cationic Host Defense and Antimicrobial Peptides

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 67-74

  Mookherjee, Neeloffer ^a   Brown, Kelly L ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856433419     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50015-5     Document Type: Chapter

References (57)

1. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000, 96:3086-3093.
2. An LL, Yang YH, Ma XT, Lin YM, Li G, Song YH, et al. LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccine. Leuk Res 2005, 29:535-543.
3. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock REW Impact of LL-37 on anti-infective immunity. J Leukoc Biol 2005, 77:451-459.
4. Bowdish DM, Davidson DJ, Scott MG, Hancock REW Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 2005 May, 49:1727-1732.
5. Bowdish D, Davidson DJ, Speert DP, Hancock REW The human cationic peptide LL-37 induce activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol 2004, 172:3758-3765.
6. Braff M, Hawkins A, Di Nardo A, Lopez-Garcia B, Howell MD, Wong C, et al. Structure-function relationships among humans cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 2005, 174:4271-4278.
7. Chan YR, Gallo RL PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130 (Cas). J Biol Chem 1998, 273:28978-28985.
8. Ciornei CD, Egesten A, Bodelsson M Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro. Acta Anaesthesiol Scand 2003, 47:213-220.
9. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, et al. The cationic antimicrobial peptide LL_37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 2004, 172:1146-1156.
10. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Investigat Dermatol 2001, 117:91-97.
11. Elssner A, Duncan M, Gavrilin M, Wewers MD A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces LL-1β processing and release. J Immunol 2004, 172:4987-4994.
12. Finlay BB, Hancock REW Can innate immunity be enhanced to treat infections?. Nature Microbiol Rev 2004, 2:497-504.
13. Fukumoto K, Nagaoka I, Yamataka A, Kobayashi H, Yanai T, Kato Y, et al. Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats. Pediatr Surg Int 2005, 21:20-24.
14. Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 1994, 91:11035-11039.
15. Gao Y, Lecker S, Post MJ, Hietaranta AJ, Li J, Volk R, et al. Inhibition of ubiquitin-proteasome pathway-mediated Iκ{script}Bα degradation by a naturally occurring antibacterial peptide. J Clin Invest 2000, 106:439-448.
16. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'Amato G, Circo R, et al. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. Am J Respir Crit Care Med 2004, 169:187-194.
17. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R The human gene FALL-39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996, 238:325-332.
18. Hancock REW, Rozek A Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett 2002, 206:143-149.
19. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF Cell differentiation is a key determinant of cathelicidin LL-37/Human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002, 70:953-963.
20. Heiborn JD, Nilsson MF, Jimenez CI, Sandstedt B, Borregaard N, Tham E, et al. Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 2005, 114:713-719.
21. Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, Borregaard N, et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003, 120:379-389.
22. Hiemstra PS, Fernie-King BA, McMichael J, Lachmann PJ, Sallenave JM Antimicrobial peptides: mediators of innate immunuty as templates for the development of novel anti-infective and immune therapeutics. Curr Pharmaceut Design 2004, 10:2891-2905.
23. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol 2005, 174:4901-4907.
24. Islam D, Bandholz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001, 7:180-185.
25. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003, 111:1665-1672.
26. Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol 2005, 174:6257-6265.
27. Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock REW Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun 2005, 73:583-591.
28. Li J, Post M, Volk R, Gao Y, Li M, Metais C, et al. PR39, a peptide regulator of angiogenesis. Nature Medicine 2000, 6:49-55.
29. Mookherjee N, Brown KL, Bowbish DEM, Doria S, Falsafi R, Hokamp K, et al. Modulation of the TLR-mediated inflammatary response by the endogenous human host defense peptide LL-37. J Immunol 2006, 176:2455-2464.
30. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, et al. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 2001, 167:3329-3338.
31. Nilsson MF, Sandstedt B, Sörensen O, Weber G, Borregaard N, Sthle-Bäckdahl M The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelial and colocalizes with interleukin-6. Infect Immun 1999, 67:2561-2566.
32. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunol 2002, 106:20-26.
33. Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 2001, 31:1066-1075.
34. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001, 414:454-457.
35. Ohgami K, Ilieva IB, Shiratori K, Isogai E, Yoshida K, Kotake S, et al. Effect of human cationic antimicrobial protein 18 peptide on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2003, 44:4412-4418.
36. Okumura K, Itoh A, Isogai E, Hirose K, Hosokawa Y, Abiko Y, et al. C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett 2004, 212:185-194.
37. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. New Engl J Med 2002, 347:1151-1160.
38. Putsep K, Carlsson G, Boman HG, Andersson M Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002, 360:1144-1149.
39. Rosenberger CM, Gallo RL, Finlay BB Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replications. Proc Natl Acad Sci USA 2004, 101:2422-2427.
40. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock REW The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 2002, 169:3883-3889.
41. Shaykhiev R, Beisswenger C, Kaendler K, Senske J, Puechner A, Damm T, et al. The human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 2005, 289:L842-L848.
42. Shi J, Ganz T The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids. Infect Immun 1998, 66:3611-3617.
43. Shi J, Ross CR, Leto TL, Blecha F PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47phox. Proc Natl Acad Sci USA 1996, 93:6014-6018.
44. Sorensen OE, Borregaard N Cathelicidins: Nature's attempt at combinatorial chemistry. Comb Chem High Throughput Screen 2005, 8:273-280.
45. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001, 97:3951-3959.
46. Steinberg DA, Hurst MA, Fujii CA, Kung AH, Ho JF, Cheng FC, et al. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 1997, 41:1738-1742.
47. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth facctor receptor. J Immunol 2003, 171:6690-6696.
48. Tomasinsig L, Zanetti M The cathelicidins-Structure, function and evolution. Current Protein and Peptide Sci 2005, 6:23-34.
49. Uzzel T, Stolzenberg ED, Shinnar AE, Zasloff M Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides 2003, 24:1655-1667.
50. Wu J, Parungo C, Wu G, Kang PM, Laham RJ, Selke FW, et al. PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2. Circulation 2004, 109:1660-1667.
51. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ Multiple roles of antmicrobial defensins, cathelicidins and eosinophil-derived neurotoxin in host defense. Ann Rev Immunol 2004, 22:181-215.
52. Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, et al. LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000, 192:1069.
53. Zanetti M, Del Sal G, Storici P, Schneider C, Romeo D The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. J Biol Chem 1993, 268:522-526.
54. Zanetti M, Gennaro R, Romeo D Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995, 274:1-5.
55. Zasloff M Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
56. Zhang L, Falla TJ Cationic antimicrobial peptides-an update. Exp Opin Investigat Drugs 2004, 13:97-106.
57. Zhao C, Ganz T, Lehrer RI Structures of genes for two cathelinassociated antimicrobial peptides: prophenin-2 and PR-39. FEBS Lett 1995, 376:130-134.